Membrane attack complex and membrane cofactor protein are related to tubulointerstitial inflammation in various human glomerulopathies

Nephron

Volumn 75, Issue 2, 1997, Pages 179-187

  Mosolits, Szilvia ^a   Magyarlaki, Tamas ^a   Nagy, Judit ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Human glomerulopathies; Membrane attack complex; Membrane cofactor protein; Tubulointerstitial inflammation

Indexed keywords

COMPLEMENT MEMBRANE ATTACK COMPLEX; MEMBRANE COFACTOR PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULOPATHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY BIOPSY; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; TISSUE INJURY;

EID: 0031047306     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189529     Document Type: Article

References (33)

1. Bohle A. Slrutz F. Müller GA: On the pathogenesis of chronic renal failure in primary glomerulopathies. A view from the intersti-tium. Exp Nephrol 1994;2:205-210.
2. Fine LG. Ong ACM, Norman IT: Mechanisms of tubulo-interstitial injury in progressive renal disease. Eur J Clin Invest 1993:23:259-265.
3. Cameron JS: Tubular and interstitial factors in the progression of glomerulonephritis. Pedialr Nephrol 1992:6:292-303.
4. Bohle A, Mackensen-Haen S. von Gise H. Grund KE. Whcrmann M. Batz C, Bogen-schiitz O. Schmitt H, Nagy J. Müller CA. Muller GA: The consequences of tubulo-interstitial changes for renal function in glomerulopathies. Pathol ResPract 1990:186:135-144.
5. Bohle A. Whcrmann M, Mackensen-Haen S. von Gise H. Mickelcr E. Xiao TC. Müller C, Müller GA: Pathogenesis of chronic renal failure in primary glomerulopathies. Nephrol Dial Transplant 1994;3(suppl):4-12.
6. Hooke DH, Gee DC, Atkins RC: Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 1987:31: 964-972.
7. Lan HY, Paterson DJ. Atkins RC: Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. Kidney Int 1991;40:425-433.
8. Schulze M, Pruchno CJ. Burns M. Baker PJ. Johnson RJ, Couser WG: Glomerular C'3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis. Am J Pathol 1993;142:179-187.
9. Hinglais N, Kazatchkine MD. Bhakdi S. Appav MD. Mandel C. Grossetetc J. Bariety J: Immunohistochemical study of the C5b-9 complex of complement in human kidneys. Kidney Int 1986:30:399-410.
10. Groggel GC, Adler S, Rennke HG. Couser WG. Salant DJ: Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit. J Clin Invest 1983; 72:1948-1957.
11. Groggel GC. Salant DJ. Darby C. Rennke HG. Couscr WG: Role of terminal complement pathway in the heterologous phase of antiglom-erular basement membrane nephritis. Kidney Int 1985:27:643-651.
12. Akano N, Yoshioka K. Aya N, Miyamoto H. Takemura T, Tohda M. Maki S: Immunoelcc-tron microscopic localization of membrane attack complex and hepatitis B e antigen in membranous nephropathy. Virchows Arch [A] 1989:414:325-330.
13. Miyamoto H, Yoshioka K, Takemura T, Akano N. Maki S: Immunohistochemical study of the membrane attack complex of complement in IgA nephropathy. Virchows Arch [A] 1988: 413:77-86.
14. AIcxopoulos E. Papaghianni A. Papadimitriou M: The pathogenetic significance of C5b-9 in IgA nephropathy. Nephrol Dial Transplant 1995:10:1166-1172.
15. Koefflcr D. Biesecker G. Noble B. Andres GA. Hernandez AM: Localization of the membrane attack complex (MAC) in experimental immune complex glomerulonephritis. J Exp Med 1983:157:1885-1905.
16. French LE. Tschopp J. Schifferli JA: Clusterin in renal tissue: Preferential localization with the terminal complement complex and immunoglobulin deposits in glomeruli. Clin Exp Immunol 1992;88:389-393.
17. Biesecker G. Katz S, Koffler D: Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis. J Exp Med 1981:154:1779-1794.
18. F-ndoh M. Yamashina M. Ohi H. Funahashi K. Ikuno T. Yasugi T. Atkinson JP. Okada H: Immunohistochemical demonstration of membrane cofactor protein (MC'P) of complement in normal and diseased kidney tissues. Clin Exp Immunol 1993;94:182-188.
19. Nakanishi I, Moutabarrik A. Hara T. Hatanaka M. Hayashi T, Syouji T, Okada N. Kitamura E, Tsubakihara Y, Matsumoto M. Seya T: Identification and characterization of membrane cofactor protein (CD46) in the human kidneys. Eur J Immunol 1994:24:1529-1535.
20. Shibata T. Cosio FG. Birmingham DJ: Complement activation induces the expression of decay accelerating factor on human mesangial cells. J Immunol 1991:147:3901-3908.
21. Tamai H, Matsuo S. Fukatsu A. Nishikawa K. Sakamoto N. Yoshioka K, Okada N. Okada H: Localization of 20-kD homologous restriction factor (HRF20) in diseased human glomeruli. An immunofluorescence study. Clin Exp Immunol 1991:84:256-262.
22. Ichida S. Yuzawa Y. Okada H. Yoshioka K. Matsuo S: Localization of the complement regulatory proteins in the normal human kidney. Kidney Int 1994:46:89-96.
23. Tisher CC, Brenner BM: Renal Pathology. Philadelphia. Lippincolt, 1989.
24. Balogh P, Szckeres GY, Nemeth P: Hapten-mediated identification of cell membrane antigens using an anti-FITC monoclonal antibody. J Immunol Methods 1994; 169:35-40.
25. Aheme WA. Dunnill MS: Morphometry. London, Arnold. 1982, p 33.
26. Vlaicu R. Niculescu F, Rus HG, Cristea A: Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque. Atherosclerosis 1985:57: 163-177.
27. Magil AB. Tyler M: Tubulo-interstitial disease in lupus nephritis. A morphometric study. His-topalhology 1984:8:81-87.
28. Park MH, D'Agati V, Appel GB, Pirani CL: Tubulointerstitial disease in lupus nephritis: Relationship to immune deposits, interstitial inflammation, glomerular changes, renal function and prognosis. Nephron 1986:44:309-319.
29. Hansch GM: The complement attack phase: Control of lysis and non-lethal effects of C5b-9. lmmunopharmacology 1992:24:107-117.
30. Wagner C. Braunger M. Beer M. Rother K. Hansch GM: Induction of matrix protein synthesis in human glomerular mesangial cells by the terminal complement complex. Exp Nephrol 1994:2:51-56.
31. Hansch GM, Torbohm I. Rother K: Chronic glomerulonephritis: Inflammatory mediators stimulate the collagen synthesis in glomerular epithelial cells. Int Arch Allergy Appl Immunol 1989:88:139-143.
32. Ong ACM. Fine LG: Tubular derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: Implications for human renal disease progression. Am J Kidney Dis 1994:23:205-209.
33. Okada M, Yoshioka K. Takemura T, Akano N. Aya N, Murakami K, Maki S: Immunohistochemical localization of C3d fragment of complement and S-protein (vitronectin) in normal and diseased human kidneys: Association with the C5b-9 complex and vitronectin receptor. Virchows Arch [A] 1993:422:367-373.